Combiflam, a commonly-used painkiller from the Sanofi stable, has failed the disintegration test, and several batches of the drug have been recalled from the market.

The Central Drugs Standard Control Organisation (CDSCO) has ordered the recall.

Sanofi described the procedure as a ‘Class III recall’ which means taking the already available batches of medicine will not have any adverse health consequences. Four batches have been recalled by the drug regulator, the pharmaceutical company said. The batches were made between June and July 2015, and carried expiry dates between May and June 2018.

Drugs taken break into granules inside the body and then become effective. The disintegration test predicts the time taken by a medicine to take effect.


Guide to approaching a consumer court

India's first practical guide to resolving your complaints by approaching consumer court. Guidance
Customer Complaint


Enter your email address to subscribe to our Newsletter.